Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third Dose of BBIBP-CorV in Elderly with Hypertension or Diabetes
NCT05104333Phase 4Unknown
- Sponsor
- China National Biotec Group
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by China National Biotec Group. Status: unknown.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05104333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05104333.